Liver disease treatment in India for Kazakhstani patients has become one of the most sought-after medical travel options in Central Asia—and for a very clear reason. Kazakhstan has a chronic hepatitis B epidemic that no other Central Asian country faces to the same degree. Between 3 and 4 percent of Kazakhstan’s population carries a chronic hepatitis B infection. In real terms, approximately 600,000 to 800,000 Kazakhstanis are living with chronic HBV—and a significant proportion will progress to liver cirrhosis, liver failure, or hepatocellular carcinoma (liver cancer) without adequate treatment.
The treatment pathway in Kazakhstan—antiviral therapy, regular monitoring, FibroScan, liver biopsy, and ultimately transplant evaluation—is available, but often at prices that are prohibitive in private hospitals and with waiting times in the public system that can span years. That is why liver disease treatment in India has emerged as the most cost-effective and clinically advanced alternative in the region. This guide explains exactly what India offers, what it costs, and which hospitals deliver the best results for CIS patients.
Kazakhstan’s Liver Disease Burden — Why This Matters for Your Treatment Decision
Kazakhstan has a well-documented clinical course for hepatitis B. Chronic HBV infection causes continuous liver inflammation. This inflammation damages the liver over years and causes scarring (fibrosis). If left untreated or not managed properly, fibrosis progresses to cirrhosis, in which the architecture of the liver is permanently altered, and its functions gradually deteriorate.
Serious complications at the cirrhosis stage include portal hypertension, esophageal varices, ascites, spontaneous bacterial peritonitis, hepatic encephalopathy, and hepatorenal syndrome. Liver cancer, called hepatocellular carcinoma (HCC), occurs in 2–5% of people with cirrhosis each year. Eventually, a liver transplant becomes a cure for many patients.
The progression is well known to India’s hepatologists, since they deal with it on a daily basis. In total, the Institute of Liver and Biliary Sciences (ILBS) in Delhi and the Medanta Liver Institute and hepatobiliary program of BLK-Max treat thousands of liver diseases related to hepatitis B every year, including those from Kazakhstan, Uzbekistan, and Russia. Liver disease treatment in India is available at an affordable price for Kazakhstani families and also has internationally accredited expertise!
Liver Diseases Treated in India for CIS Patients
Chronic Hepatitis B — Antiviral Therapy and Monitoring
Hepatitis B treatment in India is based on oral antiviral drugs: tenofovir (TDF), entecavir, or tenofovir alafenamide (TAF). These inhibit the further production of virus particles and thus stop further damage to the liver. The price of a year’s supply of 100% tenofovir (generic) in India is $1.20 to $20.00. The same drug in the private pharmacies in Kazakhstan costs $100 – $150 per year. Hepatitis B treatment in India is made more affordable by its government-approved generic manufacturing process.
Treatment also involves regular monitoring (viral load test (HBV DNA), liver function tests (LFT), α-fetoprotein (AFP) testing (cancer monitoring), and fibroscan (every 6-12 months)). These can all be organized during a planned visit to India, and the outcomes can be followed up on in Kazakhstan.
Hepatitis C — Curative Treatment in India
The treatment for Hepatitis C is 12-week direct-acting antivirals (DAAs): sofosbuvir-ledipasvir, sofosbuvir-velpatasvir, or glecaprevir-pibrentasvir. In most of the genotypes, the cure rate is more than 95 percent. The cost of the entire 12-week generic DAA treatment is $500-$1,500 in India, which is 20 times cheaper than branded DAA treatment in the USA, $30,000-$80,000 in Kazakhstan’s private healthcare system, and $1,500-$4,000 in Pakistan. Treatment of Hepatitis C can be organized by MediKaya Healthcare, and all the tests can be conducted in a single organized visit to India—viral genotyping, treatment, and end-of-treatment viral load testing.
Liver Cirrhosis — Management and Complication Control
Liver cirrhosis treatment in India includes all the evidence-based complication management, which involves diuretics for ascites, beta-blockers for portal hypertension, banding for esophageal varices, and TIPS (Transjugular Intrahepatic Portosystemic Shunt) for refractory ascites and hepatic encephalopathy management. While liver cirrhosis is permanent, its symptoms can be managed so as to maintain a good quality of life and limit the progression of the disease. Assessment of MELD score determines eligibility for liver transplant—a MELD score of 15 or higher is considered a good indication that a liver transplant should be considered.
Non-Alcoholic Fatty Liver Disease (NAFLD) and NASH
The treatment of fatty liver disease takes care of one of the most prevalent liver diseases in the world, which is also called NAFLD (Non-Alcoholic SteatoHepatitis). The obesity rates in Kazakhstan are on the rise, and so is the number of cases that require treatment for NAFLD in India. Lifestyle counseling, antioxidant drugs, and bariatric surgery (known to reverse NAFLD in obesity) are used by hepatologists to treat fatty liver in India. MediKaya Healthcare arranges combined gastroenterology and bariatric consultations for patients who have liver disease related to obesity.
Hepatocellular Carcinoma (Liver Cancer)—Treatment in India
Treatment of HCC arising from hepatitis B cirrhosis includes surgery (hepatectomy), ablation (radiofrequency or microwave), transarterial chemoembolization (TACE), targeted therapy (sorafenib or lenvatinib), and liver transplant (if within Milan criteria). The teams in interventional hepatology in India conduct hundreds of cases of TACE and device ablations every year at 60-70% lower prices than the European centers.
Liver Disease Treatment Cost in India vs Kazakhstan vs Turkey — 2026
| Procedure | 🇮🇳 India | 🇰🇿 Kazakhstan | 🇹🇷 Turkey | 🇩🇪 Germany |
|---|---|---|---|---|
| Hepatitis C — Full 12-week DAA course | $500–$1,500 | $3,000–$8,000 | $2,000–$5,000 | $8,000–$2,000 |
| Hepatitis B Antiviral (1 year, generic) | $200–$400 | $800–$1,500 | $600–$1,200 | $2,000–$4,000 |
| Fibroscan (Liver Stiffness Test) | $60–$120 | $200–$400 | $150–$300 | $300–$600 |
| Liver Biopsy | $300–$600 | $800–$1,500 | $600–$1,200 | $1,500–$3,000 |
| TIPS Procedure | $2,000–$4,000 | $6,000–$12,000 | $5,000–$9,000 | $12,000–$20,000 |
| TACE for Liver Cancer | $2,500–$4,500 | $7,000–$12,000 | $5,000–$9,000 | $12,000–$22,000 |
| Liver Transplant (Living Donor) | $22,000–$27,000 | Limited / $50,000 | $35,000–$50,000 | $100,000–$150,000 |
Living Donor Liver Transplant—Can a Family Member from Kazakhstan Donate?
Yes—and this is the most important question for families looking for liver disease treatment in India for Kazakhstani patients who need a liver transplant. In a living donor liver transplant (LDLT), approximately 60 percent of the donor’s liver is used for the transplant recipient. The other part of the liver grows back to its normal size in 6-8 weeks. The hospital stay is 5-7 days, and complete recovery to normal activity is 4-6 weeks.
The following persons can be living donors in Kazakhstan: parents, siblings, adult children (aged 18 years and over), and spouses. The first requirement is blood group compatibility. Best if between 18 – 55 years of age. The ideal BMI is less than 30. The donor should not have any major liver disease and be healthy overall. In India, an in-depth evaluation is done within seven to 14 days prior to the transplant, which includes CT liver volumetry, an echocardiogram, a psychiatric evaluation, and a full blood panel.
Top Hospitals for Liver Disease Treatment in India for Kazakhstani Patients
- Institute of Liver and Biliary Sciences (ILBS), Delhi — India’s only government hospital dedicated exclusively to liver disease. Handles the highest volume of hepatitis B-related cirrhosis in India. Significantly lower cost than private hospitals. MediKaya coordinates international patient access to ILBS.
- Medanta Liver Institute, Gurugram — Performs 200+ liver transplants annually. Led by internationally trained hepatobiliary surgeons. A comprehensive program covering all stages of liver disease from hepatitis to transplant. JCI accredited.
- BLK-Max Super Specialty Hospital, Delhi — MediKaya’s primary partner. A full liver disease program including advanced hepatology, TACE, ablation, and liver transplant. Russian-speaking CIS patient coordinator on staff.
- Fortis Memorial Research Institute, Gurugram — Strong liver program, particularly for advanced cirrhosis and hepatocellular carcinoma. JCI accredited. International patient department with experienced coordination team.
Frequently Asked Questions
Q: How much does hepatitis B treatment cost in India for Kazakhstani patients?
A: The cost of chronic Hepatitis B management, hepatitis B treatment in India, is $200-$400 per year for antiviral drugs (generic tenofovir or entecavir), which is 60-80% cheaper than private drugs in Kazakhstan. The comprehensive monitoring visit to India, which includes viral load testing, LFT, AFP, FibroScan, and specialist consultation, comes down to $400 to $800. MediKaya Healthcare can arrange liver disease treatment in India for Kazakhstani patients as a structured 3-5 day visit.
Q: Can hepatitis C be cured in India?
A: Yes. Hepatitis C can be cured with direct-acting antivirals (DAAs) for 12 weeks. The cure rate is more than 95 percent. The total cost of the hepatitis C treatment with generic DAA in Kazakhstan is $500-1500 in the private clinics, whereas in India it is $3000-8000. MediKaya organizes the entire course of treatment, from viral genotyping to treatment and post-treatment viral load testing.
Q: What documents should I send to get a free liver disease evaluation?
A: For liver disease treatment in India for Kazakhstan patients, send liver function tests (ALT, AST, bilirubin, albumin, INR/prothrombin time); Hepatitis B surface antigen status; Hepatitis B viral load (HBV DNA); alpha-fetoprotein (AFP); an abdominal ultrasound or CT scan report; and any previous FibroScan results. WhatsApp these to MediKaya Healthcare for a free specialist review within 48 hours.
Q: How is liver cirrhosis different from liver failure?
A: Liver cirrhosis is a stage of chronic liver damage where scar tissue replaces healthy liver cells. The liver is damaged but still functioning — though with reduced capacity. Liver failure means the liver can no longer perform its essential functions. Cirrhosis can be compensated (functioning, manageable) or decompensated (failing, with complications like ascites, encephalopathy, and bleeding). Decompensated cirrhosis requires urgent specialist intervention and often liver transplant evaluation. Liver cirrhosis treatment in India aims to prevent this progression through timely intervention.
Q: What is a MELD score, and why does it matter for liver transplants?
A: MELD (Model for End-Stage Liver Disease) is a scoring system that measures how severely a patient’s liver is failing. It is calculated from bilirubin, INR, and creatinine levels. A MELD score of 15 or above generally indicates that liver transplant should be evaluated. A score above 20 indicates moderate urgency; above 25 indicates high urgency. India’s liver transplant teams use MELD scoring to prioritise transplant cases. Send your LFT results to MediKaya Healthcare and we will calculate your approximate MELD score as part of our free evaluation.
Лечение заболеваний печени в Индии для пациентов из Казахстана — 2026
Казахстан занимает первое место в Центральной Азии по уровню хронического гепатита B: 3–4% населения — носители вируса. Именно он является основной причиной цирроза печени, печёночной недостаточности и рака печени в стране.
Стоимость лечения в Индии:
- Полный курс лечения гепатита C (12 недель): $500–$1,500 против $3,000–$8,000 в Казахстане
- Антивирусная терапия гепатита B (генерики, 1 год): $200–$400 против $800–$1,500
- Фибросканирование: $60–$120
- Пересадка печени от живого донора: $25,000–$35,000 против $100,000–$150,000 в Германии
Родственник пациента (родитель, брат/сестра, ребёнок старше 18 лет, супруг) может стать донором части печени. MediKaya Healthcare обеспечивает бесплатную оценку вашего случая за 48 часов и полное русскоязычное сопровождение.